Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for Portal Hypertension in Cirrhosis
NCT06687265Phase 2Recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Mar 2025
- Primary completion
- Mar 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of metformin in Portal Hypertension (PH), sponsored by Assistance publique - Hôpitaux de Paris. Started Mar 2025; status: recruiting.
02
Drugs
metformin
03
Conditions
Portal Hypertension (PH)
Beyond the preview
Go deeper on NCT06687265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06687265.